PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Fertilised chicken eggs could be viable for use in cancer imaging research

The fertilised eggs could cultivate tumours for imaging within seven days.

Researchers from King’s College London (KCL) have identified that fertilised chicken eggs could provide a low-cost opportunity for cancer imaging studies and radiotracer development.

Published in the Nature Imaging Journal, the study findings could offer an alternative model that can improve both ethical and economic issues for preclinical cancer research.

Dr Tim Witney, reader in molecular imaging, school of biomedical engineering and imaging sciences, KCL, said: “12 fertilised eggs cost just £45, with zero maintenance costs – a 97% saving compared to standard mouse xenografts.”

The clinical development of drugs and diagnostic imaging in cancer research usually requires the use of animal models, including mouse models. However, recreating diseases using mouse models can be expensive, time-intensive and complicated by variable tumour take-rates and the associated welfare considerations.

Fertilised chicken eggs can provide an ideal environment for tumour growth and study as they contain a highly vascularised membrane called the chicken chorioallantoic membrane (CAM).

Researchers worked to find a straight-forward protocol for the use of chick CAM in order for fertilised eggs to be widely adopted as a model for radiopharmaceutical research.

Using direct comparison studies, researchers tested the viability of the chick CAM in comparison to mouse models.

They found that the chick CAM demonstrated its potential to achieve novel radiotracer development as well as assess treatment responses in test subjects more quickly.

Additionally, results showed that it was possible to cultivate tumours for imaging in fertilised eggs within seven days.

“These eggs provided exquisite tumour images that allowed us to assess [the] delivery of tumour-targeting drugs and the effects of radiation therapy,” added Witney.

Dr Richard Southworth, reader in cardiac molecular imaging, KCL, said: “Testing new imaging agents in cancer cells in culture is a useful first step, but it only gets us so far.

“Growing tumours in a chicken egg is an interesting intermediate step which could accelerate imaging agent development at a fraction of the cost.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026